Skip to main content
Medical information Clinical review pending

Genetic Testing

Pan Fungal RNA Detection Qualitative Test

Detects RNA from various fungal pathogens to diagnose fungal infections using Real Time RT-PCR. Essential for patients with symptoms of fungal infections.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Fresh tissue biopsy specimens, skin biopsy specimens from patients with disseminated nodular skin lesions, tissue specimens (brain, skin, soft tissue, eye, bone, lung, cardiac valve, bone marrow), peripheral blood specimens, respiratory secretions.
Results
Results are typically available within 4 working days. Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Specific preparation instructions may depend on the sample type being collected.
Test priceKSh 12,240

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Pan Fungal RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of fungal infection (e.g., persistent cough, skin lesions, unexplained fever)
  • ✓Patients with compromised immune systems
  • ✓Clinical history suggestive of fungal infection
  • ✓Diagnosis of invasive fungal infections
  • ✓Monitoring treatment response in some cases
  • ✓Identification of specific fungal pathogens
02

In plain language

What this test helps you understand

This test aids in the diagnosis of fungal infections by detecting the genetic material (RNA) of various fungal pathogens. It helps clinicians identify the presence of infection, guiding appropriate treatment decisions.
The Pan Fungal RNA Detection Qualitative Test is a diagnostic tool used to identify fungal infections by detecting RNA from various fungal pathogens. This test is particularly important for patients experiencing symptoms suggestive of fungal infections, enabling timely and appropriate treatment. It utilizes the Real Time RT-PCR method for accurate detection.

This test measures the presence of fungal RNA in different sample types. Suitable samples include fresh tissue biopsies, skin biopsies from disseminated nodular skin lesions, and tissue specimens from various body sites like the brain, skin, soft tissue, eye, bone, lung, cardiac valve, and bone marrow. Peripheral blood specimens and respiratory secretions can also be analyzed.

Individuals who may benefit from this test include those with symptoms of fungal infections (like persistent cough, skin lesions, or unexplained fever), people with weakened immune systems (e.g., undergoing chemotherapy or living with HIV), and patients with a clinical history suggesting a fungal infection.

Early detection through this test allows for prompt treatment. It helps accurately identify the specific fungal pathogen, guiding targeted therapy and improving patient outcomes by reducing the risk of complications from untreated infections.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Specific preparation instructions may depend on the sample type being collected.
SampleFresh tissue biopsy specimens, skin biopsy specimens from patients with disseminated nodular skin lesions, tissue specimens (brain, skin, soft tissue, eye, bone, lung, cardiac valve, bone marrow), peripheral blood specimens, respiratory secretions.
MethodologyReal Time RT-PCR (Reverse Transcription Polymerase Chain Reaction)
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects RNA, indicating the presence of the fungus. It may not differentiate between live and dead organisms. A negative result does not completely rule out infection, especially if the sample quality is poor or the fungal load is low. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test detects the RNA (genetic material) of various fungal pathogens, indicating the presence of a fungal infection.
Samples can include tissue biopsies, skin biopsies, blood, respiratory secretions, and other tissue specimens depending on the suspected site of infection.
Results are generally available within 4 working days. You will receive notifications via email and phone.
Individuals with symptoms of fungal infections, those with weakened immune systems, or anyone with a clinical history suggesting a fungal infection should consider this test.
A positive result indicates the presence of fungal RNA and strongly suggests an active infection, but it should be interpreted by a healthcare professional in the context of your clinical picture.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp